1. Home
  2. NBHC vs AGIO Comparison

NBHC vs AGIO Comparison

Compare NBHC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$37.95

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.12

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBHC
AGIO
Founded
2009
2007
Country
United States
United States
Employees
N/A
488
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
NBHC
AGIO
Price
$37.95
$27.12
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$44.33
$35.63
AVG Volume (30 Days)
313.4K
1.6M
Earning Date
01-21-2026
02-12-2026
Dividend Yield
3.27%
N/A
EPS Growth
N/A
N/A
EPS
3.15
N/A
Revenue
$405,867,000.00
$44,791,000.00
Revenue This Year
$8.48
$28.75
Revenue Next Year
$28.10
$139.45
P/E Ratio
$12.03
N/A
Revenue Growth
1.03
36.26
52 Week Low
$32.83
$22.24
52 Week High
$44.93
$46.00

Technical Indicators

Market Signals
Indicator
NBHC
AGIO
Relative Strength Index (RSI) 40.40 44.37
Support Level $39.35 $26.66
Resistance Level $40.68 $27.61
Average True Range (ATR) 0.61 1.13
MACD -0.29 0.61
Stochastic Oscillator 8.36 50.17

Price Performance

Historical Comparison
NBHC
AGIO

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: